Literature DB >> 28165565

Decreased expression of miR-490-3p in osteosarcoma and its clinical significance.

B Tang1, C Liu, Q-M Zhang, M Ni.   

Abstract

OBJECTIVE: Increasing evidence has revealed that miRNAs play a key role in the development and progression of tumor and are being explored as a prognostic biomarker. The aim of this study was to investigate the clinical significance of miR-490-3p expression in osteosarcoma. PATIENTS AND METHODS: Quantitative real-time PCR (qRT-PCR) was used to evaluate miR-490-3p level in osteosarcoma tissues. We also analyzed the correlations between the expression level of miR-490-3p and the clinical characteristics in cases of osteosarcoma. Also, Kaplan-Meier curve and the log-rank test were conducted to detect the prognostic value of miR-490-3p. Finally, univariable and multivariable Cox regression analyses were used to evaluate independent prognostic factors.
RESULTS: MiR-490-3p expression level was significantly downregulated in osteosarcoma tissues in comparison with noncancerous bone tissues. Moreover, low miR-490-3p expression was significantly associated with distant metastasis, advanced clinical stage and poor overall survival and relapse-free survival. Univariate and multivariate analysis results indicated that miR-490-3p was an independent prognostic factor in osteosarcoma.
CONCLUSIONS: Our results showed that miR-490-3p plays critical roles in osteosarcoma progression and serves as a novel prognostic indicator and a potential therapeutic target for osteosarcoma.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28165565

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  9 in total

Review 1.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

2.  Potential targets and clinical value of miR-490-5p in hepatocellular carcinoma: a study based on TCGA, qRT-PCR and bioinformatics analyses.

Authors:  Hong Yang; Lu Zhang; Xiao-Dong Wang; Meng-Lan Huang; Peng Lin; Yu-Yan Pang; Zhen-Bo Feng; Gang Chen
Journal:  Int J Clin Exp Pathol       Date:  2018-03-01

3.  miR-409-3p suppresses the proliferation, invasion and migration of tongue squamous cell carcinoma via targeting RDX.

Authors:  Hujie Chen; Jing Dai
Journal:  Oncol Lett       Date:  2018-05-10       Impact factor: 2.967

4.  Expression level of CDC2 gene in osteosarcoma and its clinical significance.

Authors:  Gang Hou; Biying Chen; Wenbin Xu; Huiqing Zhao; Kaihua Liu; Hui Yao
Journal:  Oncol Lett       Date:  2018-03-20       Impact factor: 2.967

5.  MiR-490-3p inhibits osteogenic differentiation in thoracic ligamentum flavum cells by targeting FOXO1.

Authors:  Xiaoxi Yang; Xiaochen Qu; Xiangyu Meng; Mengtao Li; Dongwei Fan; Tianqi Fan; Ann Y Huang; Zhongqiang Chen; Chi Zhang
Journal:  Int J Biol Sci       Date:  2018-08-06       Impact factor: 6.580

6.  A microRNA profile of pediatric glioblastoma: The role of NUCKS1 upregulation.

Authors:  Laura Giunti; Martina Da Ros; Veronica De Gregorio; Alberto Magi; Samuela Landini; Benedetta Mazzinghi; Anna Maria Buccoliero; Lorenzo Genitori; Sabrina Giglio; Iacopo Sardi
Journal:  Mol Clin Oncol       Date:  2019-01-02

7.  Long Noncoding RNA CCDC144NL-AS1 Promotes the Oncogenicity of Osteosarcoma by Acting as a Molecular Sponge for microRNA-490-3p and Thereby Increasing HMGA2 Expression.

Authors:  Juliang He; Jian Guan; Shian Liao; Zhenjie Wu; Bin Liu; Hao Mo; Zhenchao Yuan
Journal:  Onco Targets Ther       Date:  2021-01-06       Impact factor: 4.147

Review 8.  MicroRNA-490-3p and -490-5p in carcinogenesis: Separate or the same goal?

Authors:  Yin Li; Dongmei Tian; Hao Chen; Yuanting Cai; Sang Chen; Shiwei Duan
Journal:  Oncol Lett       Date:  2021-07-22       Impact factor: 2.967

9.  Biomarker potential of lncRNA GNAS-AS1 in osteosarcoma prognosis and effect on cellular function.

Authors:  Zhanhu Mi; Yanyun Dong; Zhibiao Wang; Peng Ye
Journal:  J Orthop Surg Res       Date:  2021-07-28       Impact factor: 2.359

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.